Peter Diamandis is a partner at BOLD Capital Partners, the venture firm he co-founded in 2015 to invest in exponential technologies and longevity companies. Before and alongside BOLD he founded the XPRIZE Foundation, where he is Executive Chairman, and was the Executive Founder of Singularity University, which he started with Ray Kurzweil in 2008. He is also a co-founder and Vice-Chairman of Celularity and Vaxxinity and co-founder and Chairman of Fountain Life, and by XPRIZE's own account has started over 25 companies across health-tech, space, venture capital and education. He holds degrees in molecular genetics and aerospace engineering from MIT and an M.D. from Harvard Medical School.
Education
Degrees in molecular genetics and aerospace engineering, Massachusetts Institute of Technology
Master's degree in Aeronautics, Massachusetts Institute of Technology
M.D., Harvard Medical School
Previous Experience
Founder, Zero-G Corporation
Founder & Executive Chairman, XPRIZE Foundation
Executive Founder, Singularity University
Co-founder, Human Longevity, Inc.
Co-founder & Vice-Chairman, Celularity
Co-founder & Vice-Chairman, Vaxxinity
Co-founder & Chairman, Fountain Life
Notable Investments
VaxxinityCelularityMYOS Corp3D Systems Corporation
Board Seats
XPRIZE Foundation
Celularity
Vaxxinity
Fountain Life
Career Timeline
1993
Founded Zero-G Corporation to offer commercial weightless flights to NASA and the public.
1996
XPRIZE, which he founded, launched the $10 million Ansari XPRIZE.
2008
Co-founded Singularity University with Ray Kurzweil.
2013
Co-founded Human Longevity, Inc.
2015
Co-founded BOLD Capital Partners, which filed with the SEC to raise a $200 million venture fund.